Pregabalin Market to Grow by USD 153.03 Mn from 2022 to 2026, Driven by Presence of Large Patient Pool Related To Neuropathic Pain - Technavio

NEW YORK, Oct. 5, 2022 /PRNewswire/ -- The Global Pregabalin Market by Application and Geography – Forecast and Analysis 2022-2026 size is expected to grow by USD 153.03 million from 2022 to 2026, at a CAGR of 3.74%. The increasing presence of a large patient pool related to neuropathic pain, the increasing geriatric population, and the rising applications of pregabalin in various diseases are the major factors propelling the market growth. However, the growing preference for alternatives and stringent regulatory policies may impede market growth. To get more insights on drivers and challenges Request a Sample PDF

• Market Driver: The presence of a large patient pool related to neuropathic pain is one of the key drivers supporting the pregabalin market growth. Neuropathic pain is associated with various disorders such as diabetic neuropathy, chemotherapy-induced pain, shingles, and herniated disk. There have been growing cases of these disorders, especially in the geriatric population. Meanwhile, the increasing number of individuals preferring chemotherapy for cancer treatment is fueling cases of chemotherapy-induced pain. Furthermore, according to the CDC, the incidence of shingles is approximately four per 1,000 US population annually. Overall, there are an estimated one million cases of herpes zoster in the US annually. Such a scenario will lead to an increase in the adoption of pregabalin, which, in turn, will drive the growth of the market during the forecast period.
• Market Challenges: Growing preference for alternatives is one of the key factors hindering the pregabalin market growth. As the current treatments are associated with many unmet needs, end-users are looking to shift to alternative therapies. For instance, diabetic neuropathic pain can be reduced by supplementing essential acids, alpha-lipoic acid, gamma-linolenic acid, and omega-3 fatty acids. Similarly, acupuncture can be an effective way to manage peripheral neuropathy. Acupuncture uses pressure points across the body to realign the body's energy. Thus, the use of these alternative therapies may hinder growth prospects in the forecast period.

To get insights about additional key drivers, trends, and challenges available with Technavio. Read our Sample Report right now!

North America will be the leading region with 36% of the market's growth during the forecast period. The US and Canada are the key countries for the pregabalin market in North America. The increase in the older population, coupled with the established adoption of LYRICA and Cymbalta in new indications and the introduction of new drugs for the treatment of neuropathic pain, will facilitate the pregabalin market growth in North America over the forecast period.

The Neuropathic pain application segment will contribute the highest market share growth during the forecast period. Neuropathic pain affects 20% to 30% of diabetic neuropathy patients. Thus, the demand for pregabalin is rising due to more occurrences of diabetic neuropathy, which is boosting the growth of the market. Pregabalin is an alternative treatment for people with neuropathic pain that has not responded to other drugs. It effectively reduces the symptoms of numerous neuropathic pain conditions and positions itself as a first-line therapy option with exceptional safety and efficacy. These factors will drive segment growth during the forecast period.

View our sample report for additional insights into the contribution of all the segments, and regional opportunities in the report.

• Biomax Biotechnics Pvt. Ltd.
• Camber Pharmaceuticals Inc.
• Cipla Ltd.
• Dr. Kumars Pharmaceuticals
• Genesis Biotec Inc.
• H. L. Healthcare Pvt. Ltd.
• Lupin Ltd
• Medley Pharmaceuticals Ltd.
• MK Medicine
• MSN Laboratories
• Neuracle Lifesciences Pvt. Ltd.
• Novartis AG
• Pfizer Inc.
• Phoenix Biologicals Pvt. Ltd.
• Sun Pharmaceutical Industries Ltd
• Swastik Life Sciences
• Torrent Pharmaceuticals Ltd.
• Vibcare Pharma Pvt. Ltd.

Pharmaceuticals Wholesale and Distribution Market by Types of Drugs and Geography – Forecast and Analysis 2021-2025

Marine Pharmaceuticals Market by Product and Geography – Forecast and Analysis 2022-2026

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market Definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026 
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers 
• Exhibit 18: Chart on the Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers 
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants 
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes 
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

• 5.1 Market segments
• Exhibit 24: Chart on Application - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Application - Market share 2021-2026 (%)

• 5.2 Comparison by Application 
• Exhibit 26: Chart on Comparison by Application
• Exhibit 27: Data Table on Comparison by Application

• 5.3 Neuropathic pain - Market size and forecast 2021-2026 
• Exhibit 28: Chart on Neuropathic pain - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Neuropathic pain - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Neuropathic pain - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Neuropathic pain - Year-over-year growth 2021-2026 (%)

• 5.4 Epilepsy - Market size and forecast 2021-2026 
• Exhibit 32: Chart on Epilepsy - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Epilepsy - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Epilepsy - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Epilepsy - Year-over-year growth 2021-2026 (%)

• 5.5 Anxiety disorders - Market size and forecast 2021-2026 
• Exhibit 36: Chart on Anxiety disorders - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Anxiety disorders - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Anxiety disorders - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Anxiety disorders - Year-over-year growth 2021-2026 (%)

• 5.6 Others - Market size and forecast 2021-2026 
• Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)

• 5.7 Market opportunity by Application 
• Exhibit 44: Market opportunity by Application ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview 
• Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation 
• Exhibit 46: Chart on Market share by geography 2021-2026 (%)
• Exhibit 47: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison 
• Exhibit 48: Chart on Geographic comparison
• Exhibit 49: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026 
• Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026 
• Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026 
• Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026 
• Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026 
• Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Germany - Market size and forecast 2021-2026 
• Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.9 Canada - Market size and forecast 2021-2026 
• Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 7.10 China - Market size and forecast 2021-2026 
• Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.11 Japan - Market size and forecast 2021-2026 
• Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)

• 7.12 Republic of Korea - Market size and forecast 2021-2026 
• Exhibit 86: Chart on Republic of Korea - Market size and forecast 2021-2026 ($ million)
• Exhibit 87: Data Table on Republic of Korea - Market size and forecast 2021-2026 ($ million)
• Exhibit 88: Chart on Republic of Korea - Year-over-year growth 2021-2026 (%)
• Exhibit 89: Data Table on Republic of Korea - Year-over-year growth 2021-2026 (%)

• 7.13 Market opportunity by geography 
• Exhibit 90: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges 
• Exhibit 91: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 92: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 93: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 94: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 95: Vendors covered

• 10.2 Market positioning of vendors 
• Exhibit 96: Matrix on vendor position and classification

• 10.3 Biomax Biotechnics Pvt. Ltd. 
• Exhibit 97: Biomax Biotechnics Pvt. Ltd. - Overview
• Exhibit 98: Biomax Biotechnics Pvt. Ltd. - Product / Service
• Exhibit 99: Biomax Biotechnics Pvt. Ltd. - Key offerings

• 10.4 Camber Pharmaceuticals Inc. 
• Exhibit 100: Camber Pharmaceuticals Inc. - Overview
• Exhibit 101: Camber Pharmaceuticals Inc. - Product / Service
• Exhibit 102: Camber Pharmaceuticals Inc. - Key offerings

• 10.5 Cipla Ltd.
• Exhibit 103: Cipla Ltd. - Overview
• Exhibit 104: Cipla Ltd. - Business segments
• Exhibit 105: Cipla Ltd. - Key news
• Exhibit 106: Cipla Ltd. - Key offerings
• Exhibit 107: Cipla Ltd. - Segment focus

• 10.6 Genesis Biotec Inc.
• Exhibit 108: Genesis Biotec Inc. - Overview
• Exhibit 109: Genesis Biotec Inc. - Product / Service
• Exhibit 110: Genesis Biotec Inc. - Key offerings

• 10.7 Lupin Ltd
• Exhibit 111: Lupin Ltd - Overview
• Exhibit 112: Lupin Ltd - Product / Service
• Exhibit 113: Lupin Ltd - Key news
• Exhibit 114: Lupin Ltd - Key offerings

• 10.8 Medley Pharmaceuticals Ltd. 
• Exhibit 115: Medley Pharmaceuticals Ltd. - Overview
• Exhibit 116: Medley Pharmaceuticals Ltd. - Product / Service
• Exhibit 117: Medley Pharmaceuticals Ltd. - Key offerings

• 10.9 MK Medicine
• Exhibit 118: MK Medicine - Overview
• Exhibit 119: MK Medicine - Product / Service
• Exhibit 120: MK Medicine - Key offerings

• 10.10 Novartis AG
• Exhibit 121: Novartis AG - Overview
• Exhibit 122: Novartis AG - Business segments
• Exhibit 123: Novartis AG - Key offerings
• Exhibit 124: Novartis AG - Segment focus

• 10.11 Pfizer Inc.
• Exhibit 125: Pfizer Inc. - Overview
• Exhibit 126: Pfizer Inc. - Product / Service
• Exhibit 127: Pfizer Inc. - Key news
• Exhibit 128: Pfizer Inc. - Key offerings

• 10.12 Torrent Pharmaceuticals Ltd. 
• Exhibit 129: Torrent Pharmaceuticals Ltd. - Overview
• Exhibit 130: Torrent Pharmaceuticals Ltd. - Business segments
• Exhibit 131: Torrent Pharmaceuticals Ltd. - Key offerings
• Exhibit 132: Torrent Pharmaceuticals Ltd. - Segment focus

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist 
• Exhibit 133: Inclusions checklist
• Exhibit 134: Exclusions checklist

• 11.3 Currency conversion rates for US$ 
• Exhibit 135: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 136: Research methodology
• Exhibit 137: Validation techniques employed for market sizing
• Exhibit 138: Information sources

• 11.5 List of abbreviations 
• Exhibit 139: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:[email protected]
Website: www.technavio.com/

SOURCE Technavio

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED